Panel at JPM January 2017 – Future of Life Sciences

The topic if this year’s evening event at JPM in San Francisco co-organized by BaselArea.swiss Economic Promotion, KPMG and Venture Valuation was Designing The Future in Life Sciences – A Discussion About (Human) Capital & Innovation. How will life sciences look like in – let’s say – 2030? What are sustainable and future business models for biotech … Continue reading Panel at JPM January 2017 – Future of Life Sciences

Read more

What is the value of a deal?

Venture Valuations Dr. Aitana Peire and Dr. Patrik Frei have published an article “What is the value of a deal?” in Nature Publishing Groups’ biopharmadealmakers.nature.com. The article is available online as well as in the biopharmadealmakers supplement June 2016 edition of nature biotechnology and Nature Reviews Drug Discovery. The pharmaceutical and biotechnology industries see over … Continue reading What is the value of a deal?

Read more

Life Sciences in Europe Report – Smart Site Selection

Zurich / Singapore, June 2016 – Venture Valuation together with KPMG and its new partner EuropaBio has released its third Report on “Site Selection for Life Sciences companies in Europe”. The report now also added additional countries including Denmark, Finland, Italy, Spain and Sweden. The report looks at the strength of Biotechnology, Medical Technology and … Continue reading Life Sciences in Europe Report – Smart Site Selection

Read more